Prescription drug prices: Politicians are all talk, no action
On July 26, 2020, President Donald Trump signed an executive order under which the U.S. government’s Medicare Part D program would have negotiated lower prescription drug prices based on an “International Price Index.”
Implementation of the order was delayed pending counter-proposals from Big Pharma, but the Democratic response was swift.
“Instead of meaningfully lowering drug prices, President Trump’s executive orders would hand billions of dollars to Big Pharma,” House Speaker Nancy Pelosi (D-CA) complained, without explaining why or how.